Broad microbial cells

Broad microbial cells refers to a diverse group of microscopic organisms, including bacteria, fungi, and protozoa, that can cause disease in humans (Source: NIH, 2023). This term is not a specific molecular target like a protein or receptor but rather a general category of biological entities targeted by anti-infective agents (Source: StatPearls, 2023). Drugs that interact with these cells typically aim to disrupt essential life processes unique to the microbe, such as peptidoglycan synthesis in bacteria or ergosterol synthesis in fungi (Source: PubMed, 2022). While targeting broad microbial cells is the basis for treating infections, the lack of specificity can lead to the destruction of beneficial commensal bacteria, resulting in dysbiosis (Source: Nature Reviews Microbiology, 2021). Furthermore, the widespread use of broad-spectrum agents against these cells is a primary driver of global antimicrobial resistance (Source: WHO, 2023). Because the term encompasses a vast array of distinct biological structures and pathways, it is considered too broad to serve as a specific therapeutic target in modern drug discovery (Source: FDA, 2022). Instead, researchers focus on specific molecular components within these cells to develop more precise and effective treatments.

Other names

MicroorganismsMicrobesPathogenic microbesMicrobial pathogens

Mechanisms include the inhibition of bacterial cell wall synthesis, inhibition of protein synthesis by targeting microbial ribosomes, disruption of cell membrane integrity, and inhibition of nucleic acid synthesis or function (Source: StatPearls, 2023).